LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

Kodu・Aktsiate loetelu・Vaxart Inc

Vaxart Inc

Suletud

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Põhinäitajad
By Trading Economics
Sissetulek	6.8M -8.1M
Müük	33M 72M
Kasumimarginaal	-11.242
Töötajad	105
EBITDA	6.7M -5.4M

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	19. märts 2026

Turustatistika
By TradingEconomics
Turukapital	101M 192M
Eelmine avamishind	0
Eelmine sulgemishind	0

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

0.4007 / 0.4252 Toetus ja vastupanu

Vaxart Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. märts 2026, 19:18 UTC

Suurimad hinnamuutused turgudel

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

11. märts 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

11. märts 2026, 23:54 UTC

Market Talk

Nikkei May Decline on Energy Costs Concerns -- Market Talk

11. märts 2026, 23:51 UTC

Market Talk

Gold Falls as Rising Oil Prices Spur Inflation Worries -- Market Talk

11. märts 2026, 23:41 UTC

Market Talk

REA Bull Sees Potential Upside to Yield Guidance -- Market Talk

11. märts 2026, 23:37 UTC

Market Talk

Uudisväärsed sündmused

Oil Futures Rise Amid Ongoing Middle East Conflict -- Market Talk

11. märts 2026, 23:17 UTC

Uudisväärsed sündmused

Front-Month WTI Crude Oil Futures Rise 5.5% to $92.05/bbl

11. märts 2026, 23:17 UTC

Uudisväärsed sündmused

Front-Month Crude Oil Futures Rise Amid Ongoing Middle East Conflict

11. märts 2026, 22:29 UTC

Market Talk

Australia Shares Set to Fall in Early Trade -- Market Talk

11. märts 2026, 21:47 UTC

Tulu

Liontown Resources: Market Tailwinds Strengthening Outlook

11. märts 2026, 21:46 UTC

Tulu

Liontown Resources: 4 Mln Ton Per Annum Expansion Study Underway

11. märts 2026, 21:45 UTC

Tulu

Liontown Resources Says FY26 Guidance Unchanged

11. märts 2026, 21:45 UTC

Tulu

Liontown Resources 1H Unit Operating Costs A$985/Ton

11. märts 2026, 21:44 UTC

Tulu

Liontown Resources 1H Underlying Ebitda Loss A$7.7 Million

11. märts 2026, 21:43 UTC

Tulu

Liontown Resources 1H Revenue A$207.5 Million

11. märts 2026, 21:43 UTC

Tulu

Liontown Resources 1H Net Loss A$184 Million

11. märts 2026, 21:12 UTC

Omandamised, ülevõtmised, äriostud

Netflix Rival Strikes Deal With Google in Battle for AI Content -- Barrons.com

11. märts 2026, 21:10 UTC

Tulu

Vista Gold FY25 Loss $7.5M >VGZ

11. märts 2026, 21:10 UTC

Tulu

Vista Gold FY25 Loss/Shr 6c >VGZ

11. märts 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

11. märts 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

11. märts 2026, 20:27 UTC

Omandamised, ülevõtmised, äriostud

Papa John's Draws Fresh Takeover Interest -- 2nd Update

11. märts 2026, 20:26 UTC

Tulu

These Stocks Are Today's Movers: Oracle, UniFirst, Fair Isaac, Nebius, AeroVironment, Campbell's, and More -- Barrons.com

11. märts 2026, 20:19 UTC

Uudisväärsed sündmused

The Strait of Hormuz Could Take Weeks -- Even Months -- to Reopen, Military Experts Say -- Barrons.com

11. märts 2026, 20:15 UTC

Tulu

This Physical AI Stock Jumped on Earnings. The Robots Are Coming. -- Barrons.com

11. märts 2026, 20:12 UTC

Uudisväärsed sündmused

Stock Market Today: Oil Prices Push Higher Despite IEA Oil Release Headline -- WSJ

11. märts 2026, 19:31 UTC

Market Talk

Uudisväärsed sündmused

Oil Futures Gain Despite IEA's Planned Release of Reserves -- Market Talk

11. märts 2026, 19:01 UTC

Market Talk

Uudisväärsed sündmused

U.S. Natural Gas Gains With Middle East Conflict in View -- Market Talk

11. märts 2026, 18:59 UTC

Omandamised, ülevõtmised, äriostud

Berkshire's Deal for Occidental Chemicals Unit Is a Winner as Chemical Stocks Surge -- Barrons.com

11. märts 2026, 18:43 UTC

Uudisväärsed sündmused

Chubb Named Lead Insurer for U.S. Plan to Protect Oil Tankers in Strait of Hormuz -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Vaxart Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Vaxart Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.4007 / 0.4252Toetus ja vastupanu

Recent bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.